Emerging Technologies for Non-Invasive Neurostimulation Promising Applications in Biomedical Systems

Adams Marie Kara^*
*Correspondence: Adams Marie Kara, Department of Neurology, Yale University, Connecticut, USA, Email:

Introduction

Non-invasive neurostimulation techniques have gained significant attention in the field of biomedical systems due to their potential for treating a wide range of neurological and psychiatric disorders. These techniques involve stimulating the nervous system using external devices without the need for invasive procedures such as surgery or implantation of electrodes [1]. Several emerging technologies for non-invasive neurostimulation are showing promising applications in biomedical systems. Some of these technologies include:

Transcranial Magnetic Stimulation (TMS): TMS uses magnetic fields to induce electrical currents in specific regions of the brain. It has been shown to be effective in treating depression, obsessive-compulsive disorder, and other neurological conditions. TMS is non-invasive and relatively safe, with minimal side effects. It has the potential to revolutionize the field of psychiatry and provide new treatment options for patients with mental health disorders.

Transcranial Direct Current Stimulation (tDCS): tDCS involves applying a low-intensity direct current to the scalp to modulate brain activity. It has been studied for its potential in treating various neurological conditions, including stroke, chronic pain, and addiction [2,3]. tDCS is relatively simple to administer and has shown promising results in early clinical trials, although further research is needed to fully understand its safety and efficacy.

Electroencephalography (EEG)-based neurofeedback: EEG-based neurofeedback involves measuring brain activity using electrodes placed on the scalp and providing real-time feedback to the patient. This allows individuals to learn to self-regulate their brain activity and has shown potential in treating conditions such as attention deficit hyperactivity disorder (ADHD), epilepsy, and anxiety disorders. EEG-based neurofeedback has the advantage of being non-invasive and relatively low-cost compared to other neurostimulation techniques.

Optogenetics: Optogenetics is a cutting-edge technology that involves genetically modifying neurons to express light-sensitive proteins, allowing researchers to selectively activate or inhibit specific neurons using light. This technique has shown great promise in understanding the neural circuits involved in various neurological disorders, and has the potential for precise and targeted neurostimulation. However, it is currently limited to animal research and further research is needed to develop safe and effective optogenetic techniques for humans.

Ultrasound-based neurostimulation: Ultrasound-based neurostimulation is a non-invasive technique that uses focused ultrasound waves to modulate neural activity. It has shown potential in treating conditions such as Parkinson's disease, Alzheimer's disease, and chronic pain. Ultrasound-based neurostimulation has the advantage of being able to penetrate deep into the brain with high spatial resolution, allowing for precise targeting of specific brain regions.

Virtual reality (VR) and augmented reality (AR) for neurostimulation: VR and AR technologies are increasingly being used for non-invasive neurostimulation applications. For example, virtual reality environments can be used to simulate real-world situations and provide feedback to the brain to modulate neural activity. This has shown potential in treating conditions such as phobias, post-traumatic stress disorder (PTSD), and addiction. AR technologies, on the other hand, can overlay virtual content onto the real world, providing novel ways to modulate neural activity and potentially treat neurological disorders.

Description

These emerging technologies for non-invasive neurostimulation have shown promising applications in biomedical systems, offering new and exciting possibilities for treating neurological and psychiatric disorders. However, further research is needed to fully understand their safety, efficacy, and longterm effects, and to develop standardized protocols for their clinical use. As technology continues to advance, non-invasive neurostimulation techniques have the potential to revolutionize the field of biomedical systems and greatly improve patient care [4,5].

Emerging technologies for non-invasive neurostimulation are showing great promise in the field of biomedical systems. These technologies, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), EEG-based neurofeedback, optogenetics, ultrasoundbased neurostimulation, and virtual reality/augmented reality (VR/AR) for neurostimulation, offer innovative ways to modulate neural activity without invasive procedures. They have shown potential in treating a wide range of neurological and psychiatric disorders, including depression, stroke, chronic pain, addiction, epilepsy, and phobias, among others.

Conclusion

Non-invasive neurostimulation techniques have several advantages, including being relatively safe, cost-effective, and having the potential for precise targeting of specific brain regions. However, further research is needed to fully understand their safety, efficacy, and long-term effects, and to establish standardized protocols for their clinical use. Additionally, regulatory considerations and ethical implications must be carefully addressed as these technologies continue to advance.

Despite the challenges, the rapid progress of these emerging technologies is opening up new opportunities for non-invasive neurostimulation in biomedical systems. They have the potential to revolutionize the field of neuroscience and improve patient care by providing alternative treatment options for individuals suffering from neurological and psychiatric disorders. Continued research, development, and integration of these technologies into clinical practice hold promise for advancing the field of non-invasive neurostimulation and ultimately benefiting patients worldwide.

References

1. Black, Bryan J., Rahul Atmaramani, Sarah Plagens, and Zachary T. Campbell, et al. "Emerging neurotechnology for antinoceptive mechanisms and therapeutics discovery." Biosens Bioelectron 126 (2019): 679-689.

Google Scholar, Crossref, Indexed at

2. Legon, Wynn, Tomokazu F. Sato, Alexander Opitz, and Jerel Mueller, et al. "Transcranial focused ultrasound modulates the activity of primary somatosensory cortex in humans." Nat Neurosci 17 (2014): 322-329.

Google Scholar, Crossref, Indexed at

3. Grossman, Nir, David Bono, Nina Dedic, and Suhasa B. Kodandaramaiah, et al. "Noninvasive deep brain stimulation via temporally interfering electric fields." cell 169 (2017): 1029-1041.

Google Scholar, Crossref, Indexed at

4. Ruffini, Giulio, Fabrice Wendling, Isabelle Merlet, and Behnam Molaee-Ardekani, et al. "Transcranial current brain stimulation (tCS): models and technologies." IEEE Trans Neural Syst Rehabil Eng 21 (2012): 333-345.

Google Scholar, Crossref, Indexed at

5. Yamamoto, Kazuaki, Gavin JB Elias, Michelle E. Beyn, and Ajmal Zemmar, et al. "Neuromodulation for pain: a comprehensive survey and systematic review of clinical trials and connectomic analysis of brain targets."  Stereotact Funct Neurosurg 100 (2022): 14-25.

Google Scholar, Crossref, Indexed at